6669.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 10:52):

Stats
Dzisiejszy wolumen	286 000
Średni wolumen	249 932
Kapitalizacja rynkowa	2.03B
EPS	HKD0 ( 2024-03-25 )
Następna data zysków	( HKD0 ) 2024-06-28
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	125.20
ATR14	HKD0.0270 (0.43%)

Wolumen Korelacja

Długi: -0.06 (neutral)

Krótki: 0.78 (moderate)

Signal:(31.163) Neutral

Acotec Scientific Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acotec Scientific Korelacja - Waluta/Towar

-0.42
( neutral )

-0.14
( neutral )

0.00
( neutral )

0.81
( strong )

0.37
( neutral )

-0.51
( weak negative )

Acotec Scientific Finanse

Annual	2023
Przychody:	HKD473.85M
Zysk brutto:	HKD377.42M (79.65 %)
EPS:	HKD0.0481

FY	2023
Przychody:	HKD473.85M
Zysk brutto:	HKD377.42M (79.65 %)
EPS:	HKD0.0481

FY	2022
Przychody:	HKD395.55M
Zysk brutto:	HKD336.35M (85.04 %)
EPS:	HKD0.230

FY	2021
Przychody:	HKD303.81M
Zysk brutto:	HKD265.94M (87.53 %)
EPS:	HKD-0.252

Financial Reports:

No articles found.

Acotec Scientific

Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited is a subsidiary of CA Medtech Investment (Cayman) Limited.